Drug Profile
DL 110
Latest Information Update: 21 May 2001
Price :
$50
*
At a glance
- Originator Dainippon Ink & Chemicals; Nonindustrial source
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 21 May 2001 Discontinued-Preclinical for HIV infections treatment in Japan (Unknown route)
- 14 Jul 1998 No-Development-Reported for HIV infections treatment in Japan (Unknown route)
- 28 Sep 1995 New profile